Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AIM Spotlight: Why SkinBioTherapeutics Plc (SBTX) Is Back in Focus for Investors Today

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026

AIM Spotlight: Why Shield Therapeutics Plc (STX) Is Back in Focus for Investors Today

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026

Why Investors Are Watching Time To ACT Plc (TTA) Closely on the London Stock Exchange Today

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026

Abingdon Health plc (LSE:ABDX): Why Commercialisation and Clinical Data Matter Now as FTSE AIM All-Share Investors Track the Next Catalyst

Latest focus and next watchpoint: Abingdon Health reported 30%Revenuegrowth and progress toward adjusted EBITDA profitability in the second half of FY26. It has also expanded its analytical and USManufacturingcapabilities, increasing attention on the scalability of its diagnostics platform. The next focus is recurring revenue, …

Ankur Sharma | 06 November 2026

London Small-Cap Watch: What Is Driving Avacta Group PLC (AVCT) on 6 November 2026?

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026

Cambridge Cognition Holdings plc (LSE:COG): The Pipeline Milestones Investors Are Watching as FTSE AIM All-Share Investors Track the Next Catalyst

Latest focus and next watchpoint: Cambridge Cognition remains in focus following its participation in an Imperial College-led NHS study and its SeptemberPartnershipwith C2N and The Alzheimer's Trust. The company develops digital tools for cognitive assessment and clinical research. Investors are watching clinical-study adoption, commercial …

Ankur Sharma | 06 November 2026

Eco Animal Health Group PLC (EAH) Enters the Spotlight: The Latest Catalyst and What Comes Next

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026

Fusion Antibodies plc (LSE:FAB): Clinical Progress and the Next Healthcare Catalyst as FTSE AIM All-Share Investors Track the Next Catalyst

Latest focus and next watchpoint: Fusion Antibodies reported difficult first-half trading, withRevenuefalling to about £457,000 and grossMargindropping to 10%. At the same time, its DR5 therapeutic antibody programme and OptiMAL platform showed scientific progress. The next focus is cash preservation, grant receipts, commercial pipeline …

Ankur Sharma | 06 November 2026

Faron Pharmaceuticals Oy (LSE:FARN): The Pipeline Milestones Investors Are Watching as FTSE AIM All-Share Investors Track the Next Catalyst

Latest focus and next watchpoint: Faron remains in focus around its cancer-immunotherapy pipeline, including the MATINS study and its lead development programmes. The company has flagged final melanoma survival data as an important clinical milestone. The next focus is clinical efficacy and safety data, …

Ankur Sharma | 06 November 2026

Market Focus Today: Why Feedback plc (FDBK) Could Be One to Watch on AIM

• Sector conditions can amplify moves in smaller UK-listed shares.

Ankur Sharma | 06 November 2026
Support

Hi! How can we help you today?

Loading…